BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27441744)

  • 1. Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management.
    Correa RJ; Salama JK; Milano MT; Palma DA
    Cancer J; 2016; 22(4):247-56. PubMed ID: 27441744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Strategies in Stereotactic Radiotherapy for Oligometastases.
    Palma DA; Louie AV; Rodrigues GB
    Clin Cancer Res; 2015 Dec; 21(23):5198-204. PubMed ID: 26626571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
    Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
    J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improvements of ablative local treatments modify the management of the oligometastatic disease].
    Thariat J; Vignot S; Bensadoun RJ; Mornex F
    Cancer Radiother; 2012 Sep; 16(5-6):325-9. PubMed ID: 22784592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Radiotherapy for Oligometastasis.
    Otake S; Goto T
    Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30678111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
    Radwan N; Phillips R; Ross A; Rowe SP; Gorin MA; Antonarakis ES; Deville C; Greco S; Denmeade S; Paller C; Song DY; Diehn M; Wang H; Carducci M; Pienta KJ; Pomper MG; DeWeese TL; Dicker A; Eisenberger M; Tran PT
    BMC Cancer; 2017 Jun; 17(1):453. PubMed ID: 28662647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal oligometastasis cured with stereotactic ablative radiotherapy.
    Malone J; Pantarotto JR; Tiberi D; Malone S
    Radiol Case Rep; 2020 Nov; 15(11):2266-2270. PubMed ID: 32983297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?
    Drazer MW; Salama JK; Hahn OM; Weichselbaum RR; Chmura SJ
    Expert Rev Anticancer Ther; 2016 Jun; 16(6):625-32. PubMed ID: 27078719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiotherapy in metastatic breast cancer.
    Possanzini M; Greco C
    Breast; 2018 Oct; 41():57-66. PubMed ID: 30007269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?
    Hong JC; Salama JK
    Cancer Treat Rev; 2017 Jan; 52():22-32. PubMed ID: 27886588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic ablative body radiotherapy for lung cancer.
    Franks KN; Jain P; Snee MP
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in local and ablative treatment of oligometastasis in prostate cancer.
    Yao HH; Hong MKh; Corcoran NM; Siva S; Foroudi F
    Asia Pac J Clin Oncol; 2014 Dec; 10(4):308-21. PubMed ID: 25155557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases.
    Saluja R; Cheung P; Zukotynski K; Emmenegger U
    Urol Oncol; 2016 May; 34(5):225-32. PubMed ID: 27008982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Predictive Biomarkers in Oligometastatic Disease.
    Barnum KJ; Weiss SA
    Cancer J; 2020; 26(2):100-107. PubMed ID: 32205533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stereotactic body radiation therapy for spinal metastases].
    Pasquier D; Martinage G; Mirabel X; Lacornerie T; Makhloufi S; Faivre JC; Thureau S; Lartigau É
    Cancer Radiother; 2016 Oct; 20(6-7):500-7. PubMed ID: 27614511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stereotactic body radiation therapy and oligometastases].
    Bourgier C; Azria D; Fenoglietto P; Riou O; Almaghrabi MY; Supiot S; Mornex F; Giraud P
    Cancer Radiother; 2014; 18(4):337-41. PubMed ID: 24792996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT).
    Wong AC; Watson SP; Pitroda SP; Son CH; Das LC; Stack ME; Uppal A; Oshima G; Khodarev NN; Salama JK; Weichselbaum RR; Chmura SJ
    Cancer; 2016 Jul; 122(14):2242-50. PubMed ID: 27206146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy for oligometastatic non-small cell lung cancer.
    Salama JK; Schild SE
    Cancer Metastasis Rev; 2015 Jun; 34(2):183-93. PubMed ID: 25948377
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.